97 related articles for article (PubMed ID: 1525061)
21. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Lee O; Choi MR; Christov K; Ivancic D; Khan SA
Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
[TBL] [Abstract][Full Text] [Related]
22. Antiprogestin-progesterone interactions.
Michna H; Fritzemeier KH; Parczyk K; Nishino Y; Schneider MR
Cancer Treat Res; 1996; 83():191-212. PubMed ID: 8826648
[No Abstract] [Full Text] [Related]
23. Potentiation of the antitumor effect of tamoxifen by combination with the antiprogestin onapristone.
Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):187-90. PubMed ID: 19500671
[TBL] [Abstract][Full Text] [Related]
24. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats.
Yuri T; Lai YC; Yoshizawa K; Tsubura A
In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287
[TBL] [Abstract][Full Text] [Related]
25. [Animal experimental models of breast cancer for therapeutic testing of hormones and antihormones].
Naundorf H
Arch Geschwulstforsch; 1988; 58(5):345-56. PubMed ID: 3060043
[TBL] [Abstract][Full Text] [Related]
26. [Effects of progesterone antagonists on the eosinophilic granulocytes in the rat uterus].
Schubert AK
Ann Anat; 1998 Oct; 180(5):401-8. PubMed ID: 9795690
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.
Fuhrmann U; Hess-Stumpp H; Cleve A; Neef G; Schwede W; Hoffmann J; Fritzemeier KH; Chwalisz K
J Med Chem; 2000 Dec; 43(26):5010-6. PubMed ID: 11150172
[TBL] [Abstract][Full Text] [Related]
28. Effects of antiprogestins RU486 and ZK98299 on the expression of cell cycle proteins of a medroxyprogesterone acetate (MPA)-induced murine mammary tumor.
Peters MG; Vanzulli S; Elizalde PV; Charreau EH; Goin MM
Oncol Rep; 2001; 8(2):445-9. PubMed ID: 11182072
[TBL] [Abstract][Full Text] [Related]
29. Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats.
Stoeckemann K; Hegele-Hartung C; Chwalisz K
Hum Reprod; 1995 Dec; 10(12):3264-71. PubMed ID: 8822456
[TBL] [Abstract][Full Text] [Related]
30. Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland.
Li M; Spitzer E; Zschiesche W; Binas B; Parczyk K; Grosse R
J Cell Physiol; 1995 Jul; 164(1):1-8. PubMed ID: 7790381
[TBL] [Abstract][Full Text] [Related]
31. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
32. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
35. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
36. Failure of two progesterone antagonists, mifepristone and onapristone, to affect luteal activity in lactating rats.
van der Schoot P; Uilenbroek JT; Slappendel EJ
J Reprod Fertil; 1989 Nov; 87(2):593-601. PubMed ID: 2513392
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
Matsuzawa A; Mizuno Y; Yamamoto T
Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
[TBL] [Abstract][Full Text] [Related]
38. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
Swanson SM; Christov K
Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
[TBL] [Abstract][Full Text] [Related]
39. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
Saarinen NM; Wärri A; Dings RP; Airio M; Smeds AI; Mäkelä S
Int J Cancer; 2008 Sep; 123(5):1196-204. PubMed ID: 18528864
[TBL] [Abstract][Full Text] [Related]
40. Antagonists of GHRH decrease production of GH and IGF-I in MXT mouse mammary cancers and inhibit tumor growth.
Szepeshazi K; Schally AV; Armatis P; Groot K; Hebert F; Feil A; Varga JL; Halmos G
Endocrinology; 2001 Oct; 142(10):4371-8. PubMed ID: 11564700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
